Pediatric psychopharmacology for prepubertal internalizing disorders

School Psychology Quarterly

Volumn 20, Issue 2, 2005, Pages 135-154

  Kubiszyn, Tom ^a   Carlson, John S ^b,d   Dehay, Tamara ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d University of Houston ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22144456042     PISSN: 10453830     EISSN: None     Source Type: Journal    
DOI: 10.1521/scpq.20.2.135.66513     Document Type: Article

References (93)

1. Albano, M. A., & Kendall, P. C. (2002). Cognitive behavioural therapy for children and adolescents with anxiety disorders: Clinical research advances. International Review of Psychiatry, 14, 129-134.
2. American Academy of Child and Adolescent Psychiatry (AACAP) (1997). Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10 Suppl.), 1-31.
3. American Academy of Child and Adolescent Psychiatry (AACAP) (1998a). Practice parameters for the assessment and treatment of children and adolescents with depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (10 Suppl.), 63-83.
4. American Academy of Child and Adolescent Psychiatry (AACAP) (1998b). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37 (10 Suppl.)
5. American Psychiatric Association (APA) (2000). Practice parameters for the treatment of patients with major depressive disorder [revision]. American Journal of Psychiatry, 157 (Suppl.), 1-45.
6. Asarnow, J. R., Jaycox, L. H., & Tompson, M. C. (2001). Depression in youth: Psychosocial interventions. Journal of Clinical Child Psychology, 30, 33-47.
7. Barrett, P. M. (2000). Treatment of childhood anxiety: Developmental aspects. Clinical Psychology Review, 20, 479-494.
8. Barrett, P. M., Dadds, M. R., & Rapee, R. M. (1996). Family treatment of childhood anxiety: A controlled trial. Journal of Consulting and Clinical Psychology, 64, 333-342.
9. Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 46-62.
10. Bernstein, G. A., Garfinkel, B. D., & Borchardt, C. M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 773-781.
11. Birmaher, B., Axelson, D. A., Monk, K., Kalas, C., Clark, D., & Ehmann, M. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 415-423.
12. Birmaher B., & Brent, D. A. (2003). Depressive Disorders. In Martin, A., Scahill, L., Charney, D. S. & Leckman, J. F. (Eds.), Pediatric psychopharmacology: Principles and practice. New York: Oxford University Press.
13. Black, B., & Uhde, T. W. (1994). Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1000-1006.
14. Brown, R. T. (this issue). Recent advances in pharmacotherapies for the externalizing disorders. School Psychology Quarterly, 20, 118-134.
15. Brown, R. T., & Sammons, M. T. (2002). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology: Research and Practice, 33, 13-147.
16. Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18.
17. Cobham, V. E., Dadds, M. R., & Spence, S. H. (1998). The role of parental anxiety in the treatment of childhood anxiety. Journal of Consulting and Clinical Psychology, 66, 893-905.
18. Cohen, D., Gerardin, P., Mazet, P., Purper-Ouakil, D., & Flament, M. F. (2004). Pharmacological treatment of adolescent depression. Journal of Child and Adolescent Psychopharmacology, 14, 19-31.
19. Compton, S. N., Burns, B. J., Egger, H. L., & Robertson, E. (2002). Review of the evidence base for treatment of childhood psychopathology: Internalizing disorders. Journal of Consulting and Clinical Psychology, 70, 1240-1266.
20. Cook, E. H., Wagner, K. D., March, J. S., Biederman, J., Landau, P., Wolkow, R., et al. (2001). Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1175-1181.
21. De Haan, E., Hoogduin, K., Buitelaar, J., & Keijsers, J. (1998). Behavior therapy versus cclomipramine for the treatment of obsessive compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1022-1029.
22. Delate, T., Gelenberg A. J., Simmons, V. A., & Motheral, B. R. (2004). Trends in the use of antidepressant medications in a nationwide sample of commercially insured pediatric patients, 1998-2002. Psychiatric Services, 55, 387-391.
23. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Griest, J. H., et al. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45-49.
24. DuPaul, G. J., & Carlson, J. C. (this issue). Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly, 20, 206-221.
25. Emslie, G. J., Portteus, A. M., Kumar, E. C., & Hume, J. H. (2004). Antidepressants: SSRIs and novel atypical antidepressants - An update on psychopharmacology. In H. Steiner (Ed.), Handbook of mental health interventions in children and adolescents: An integrated developmental approach (pp. 318-362). San Francisco, CA: Jossey-Bass.
26. Emslie, G. J., Rush, A. J., Weinberg, W. A., Guillion, C. M., Rintlemann, J., & Hughes, C. W. (1997). A double-blind placebo controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037
27. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Carmody, T., Mayes, T. L. (1998). Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depression and Anxiety, 7, 32-39
28. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., Mellstrom, B., et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Archives in General Psychiatry, 42, 977-983.
29. Food and Drug Administration (FDA) Talk Paper (2003, June 19). FDA Statement Regarding the Anti-Depressant Paxil for Pediatric Population. Retrieved June 26, 2003, from http://www. fda.gov/bbs/topics/ANSWERS/2003/ ANS01230.html
30. Food and Drug Administration Public Health Advisory (2003, October 27). Reports of Suicidality in Pediatric Patients Being Treated with Antidepressant Medications for Major Depressive Disorder (MDD). Retrieved November 20, 2003, from http://www.fda.gov/cder/drug/advisory/mdd.htm.
31. Food and Drug Administration Public Health Advisory (2004, March 22). Worsening Depresiion and Suicidality in Patients Being Treated with Antidepressant Medications. Retrieved June 15, 2004, from http://www.fda.gov/ cder/drug/antidepressants/AntidepressanstPHA.htm.
32. Food and Drug Administration Public Health Advisory (2004, October 21). FDA Proposed Medication Guide: About Using Antidepressants in Children and Teenagers. Retrieved Novem ber 20, 2004 from http://www.fda.gov/cder/drug/ antidepressants/SSRIMedicationGuide. htm.
33. Food and Drug Administration Proposed Medication Guide (2004, October 15). Suicidlity in Children and Adolescents Being Treated With Antidepressant Medications. Retrieved November 1, 2004 from http://www.fda.gov/cder/drug/ antidepressants/SSRIPHA200410.htm.
34. Fox, R. (2004, spring). Towards creating a real profession of psychology: A misguided emphasis on science at the expense of social relevance. Bulletin of the Psychologists in Independent Practice, 24, 2-4.
35. Franklin, M. E., Foa, E., & March, J. S. (2003). The pediatric obsessive-compulsive disorder treatment study: Rationale, design, and methods. Journal of Child and Adolescent Psychopharmacology, 13 (Suppl.), 39-51.
36. Freeman, J. B., Garcia, A. M., Fucci, C., Karitani, M., Miller, L., & Leonard, H. L. (2003). Family-based treatment of early-onset obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 1 (Suppl.), 71-80.
37. Geller, B., & DelBello, M. P. (2003). Bipolar disorderin childhood and early adolescence. New York: Guilford Press.
38. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry, 160, 1919-1928.
39. Geller, D. A., Hoog, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 773-779.
40. Geller, D. A., & Spencer, T. (2003). Obsessive-compulsive disorder. In Martin, A., Scahill, L., Charney, D. S., & Leckman, J. F. (Eds.), Pediatric psychopharmacology: Principles and practice. New York: Oxford University Press.
41. Gittleman-Klein, R., & Klein, D. (1971). Controlled imipramine treatment of school refusal. Archives of General Psychiatry, 25, 204-207.
42. Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 372-376.
43. Heard, P. M., Dadds, M. R., & Conrad, P. (1992). Assessment and treatment of simple phobias in children: Effects on family and marital relationships. Behaviour Change, 9, 73-82.
44. Hudson, J. L., Kendall, P. C., Coles, M. E., Robin, J. A., & Webb, A. The other side of the coin: Using intervention research in child anxiety disorders to inform developmental psychopathology. Development and Psychopathology, 14, 819-841.
45. Jureidini, J. N., Doecke, C. J., Mansfield, P. R., Haby, M. H., Menkes, D. B., & Tonkin, A. L. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879-883.
46. Kahn, J. S., Kehle, T. J., Jenson, W. R., Clark, E. (1990). Comparison of cognitivebehavioral, relaxation, and self-modeling interventions for depression amongmiddle-school students. School Psychology Review, 19, 196-211.
47. Kazdin, A. E., & Weisz, J. R. (1998). Identifying and developing empirically supported child and adolescent treatments. Journal of Consulting and Clinical Psychology, 66, 19-36.
48. Kendall, P. C. (1994). Treating anxiety disorders in children: Results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62, 100-110.
49. Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., Warman, M. (1997). Therapy for youths with anxiety disorders: A second randomized clinical trial. Journal of Consulting and Clinical Psychology, 65, 366-380.
50. Kendall, P. C., Safford, S., Flannery-Schroeder, E., & Webb, A. (2004). Child anxiety treatment: Outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up. Journal of Consulting and Clinical Psychology, 72, 276-287.
51. Kendall, P. C., & Southam-Gerow, M. A. (1996). Long-term follow-up of a cognitivebehavioral therapy for anxiety-disordered youth. Journal of Consulting and Clinical Psychology, 64, 724-730.
52. Kubiszyn, T. (1994) Pediatric psychopharmacology and prescription privileges: Implications and opportunities for school psychology. School Psychology Quarterly, 9, 26-40.
53. Labellarte, M. J., & Ginsburg, G. S. (2003). Anxiety disorders. In Martin, A., Scahill, L., Charney, D. S., & Leckman, J. F. (Eds.), Pediatric psychopharmacology: Principles and practice (pp. 497-510). New York: Oxford University Press.
54. Leonard, H. L., March, J., Rickler, K. C., & Allen, A. J. (1997). Review of the pharmacology of selective serotonin reuptake inhibitors in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 725-736.
55. Leonard, H. L., Swedo, S. E., Rapoport, J. L., Koby, E. V., Lenane, M. C., Cheslow, D., et al. (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088-1092.
56. Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Cheslow, D. L., Hamburger, S. D., et al. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 922-927.
57. Liddle, B., & Spence, S.H. (1990). Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy, 18, 85-102.
58. Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. R., Davies, S. O., et al. (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescentt Psychiatry, 41, 1431-1438.
59. Mackinaw-Koons, B., & Fristad, M. (2004). Children with bipolar disorder: How to break down barriers and work effectively together. Professional Psychology: Research and Practice, 35, 481-484.
60. Manassis, K. (2000). Childhood anxiety disorders: Lessons from the literature. Canadian Journal of Psychiatry, 45, 1-10.
61. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized control trial. Journal of the American Medical Association, 280, 1752-1756.
62. March, J. S., Francis, A., Carpenter, D., & Kahn, D. A. (1997). Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder. Journal of Clinical Psychiatry, 58, 2-72.
63. March, J. S., Franklin, M., Nelson, A. & Foa, E. (2001). Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. Journal of Clinical Child Psychology, 30, 8-18.
64. March, J. S., Johnston, H., Jefferson, J. W., Kobak, K. A., & Greist, J. H. (1990). Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder? Journal of Child and Adolescent Psychopharmacology, 1, 133-140.
65. March, J. S., & Wells, K. (2003). Combining pharmacotherapy and psychotherapy: An evidence-based approach. In A. Martin, L. Scahill, D. S. Charney, & J. F. Leckman (Eds.), Pediatric psychopharmacology: Principles and practice (pp. 426-446). New York: Oxford University Press.
66. Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T., & Scahill, L. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services, 54, 72-77.
67. McClellan, J. M. & Werry, J. S. (2003). Evidence-based treatments in child and adolescent psychiatry: An inventory. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1388-1400.
68. McClure, E. B., Kubiszyn, T., & Kaslow, N. J. (2002). Advances in the diagnosis and treatment of Childhood Mood Disorders. Professional Psychology: Research and Practice, 33, 125-134.
69. Medicines and Healthcare Products Regulatory Agency (MHRA) (2003, December 10). Selective Serotonin Reuptake Inhibitors - Use in Children and Adolescents with Major Depressive Disorder. Retrieved March 16, 2004, from hhrtp://www.mhra.gov.uk/news/2003. htm#ssri.
70. Mendlowitz, S. L., Manassis, K., Bradley, S., Scapillateo, D., Mieitis, S., & Shaw, B. F. (1999). Cognitive-behavioral group treatments in childhood anxiety disorders: The role of pparental involvement. Journal of the American Academy of Child andAdolescent Psychiatry, 38, 1223-1229.
71. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521.
72. Ollendick, T. H., & King, N. J. (2004). Empirically supported treatments for children and aadolescents: Advances toward evidence-based practice. In P. M. Barrert & T. H. Ollendick (Eds.), Handbook of interventions that work with children and adolescents: Prevention and treatment (pp. 3-25). New York; John Wiley & Sons.
73. Phelps, L., Brown, R. T., Power, T. J. (2002). Pediatric psychopharmacology: Combining medical and psychosocial interventions. Washington, DC: American Psychological Association.
74. Power, T. J., Eiraldi, R. B., Clarke, A. T., Mazzuca, L. B., & Krain, A. (this issue). Improving mental health service utilization for children and adolescents. School Psychology Quarterly, 20, 187-205.
75. Riddle, M. A., Kastelic, E. A., & Frosch, E. (2001). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry. 42, 73-90.
76. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive ddisorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222-229.
77. Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al.(1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062-1069.
78. Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158, 2008-2014.
79. Shortt, A. L., Barrett, P. M., & Fox, T. L. (2001). Evaluating the FRIENDS Program: A cognitive-behavioral group treatment for anxious children and their parents. Journal of Clinical Child Psychology, 30, 525-535.
80. Silverman, W. K., Kurtines, W. M., Ginsburg, G. S., Weems, C. F., Lumpkin, P. W., & Carmichael, D. H. (1999). Treating anxiety disorders in children with group cognitive-behavioral therapy: A randomized clinical trial. Journal of Consultingand Clinical Psychology, 67, 675-687.
81. Stark, K. D., Reynolds, W. M., & Kaslow, N. J. (1987). A comparison of the relative efficacy of self-control therapy and a behavioral problem-solving therapy for depression in children. Journal of Abnormal Child Psychology, 15, 91-113.
82. Stark, K. D., Rouse, L. W., & Livingston, R. (1991). Treatment of depression during childhood and adolescence: Cognitive-behavioral procedures for the individual and family. In Kendall, Philip C., Child and adolescent therapy: Cognitive-behavioral procedures. New York: Guilford Press.
83. Steinberg, L. (2002). Adolescence (6th Ed.) Boston: McGraw Hill.
84. Thienemann, M. (2004). Medications for pediatric anxiety. In H. Steiner (Ed.), Handbook of mental health interventions in children and adolescents: An Integrated Developmental Approach (pp. 288-317). San Francisco, CA: Jossey-Bass.
85. Velosa, J. F., & Riddle, M. A. (2000). Pharmacologic treatment of anxiety disorders in children and adolescents. Child & Adolescent Psychiatric Clinics of North America, 9, 119-133.
86. Vostanis, P., Feehan, C., Grattan, E., & Bickerton, W. (1996). A randomized controlled out patient trial of cognitive-behavioural treatment for children and adolescents with depression: 9-month follow-up. Journal of Affective Disorders, 40, 105-116.
87. Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M. S., Childress, A., Donnelly, C., & Deas, D. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Journal of the American Medical Association, 290, 1033-1041.
88. Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., et al. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344, 1279-1285.
89. Wegerer, V., Moll, G. H., Bagli, M., Rothenberger, A., Ruther, E., & Huether, G. (1999). Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. Journal of Child and Adolescent Psychopharmacology, 38, 13-24.
90. Weisz, J. R., Thurber, C. A., Sweeney, L., Proffitt, V. D., & LeGagnoux, G.L. (1997). Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. Journal of Consulting and Clinical Psychology, 65, 703-707.
91. Wood, A., Harrington, R., Moore, A. (1996). Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. Journal of Child Psychology and Psychiatry, 37, 737-746.
92. Zeskind, P. S., & Stephens, L. E. (2004). Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics, 113, 368-375.
93. Zito, J. M., Safer, D. J., dos Reis, S., Gardner, J. F., Magder, L., Socken, K. et al. (2003). Psychotropic Practice Patterns for Youth. Archives of Pediatrics and Adolescent Medicine, 157, 17-25.